Event Abstract

Temperature and ph sensitive polyampholytes used as protein aggregation inhibitors

  • 1 McMaster University, Department of Chemistry & Chemical Biology, Canada

Introduction: Polyampholytes may be efficiently prepared by copolymerization of cationic and anionic monomers, and exhibit distinct properties such as isoelectric points (pI), anti-polyelectrolyte effects, and often, soluble to insoluble transitions during heating. These protein-like properties give polyampholytes the potential ability to inhibit protein aggregation, and protect mammalian cells during freezing. We are preparing stoichiometric polyampholytes formed from acrylic monomers such as N-(3-aminopropyl) methacrylamide hydrochloride (APM) and acrylic acid (AA), and are exploring their solution properties and potential use as new protein aggregation inhibitors and cryoprotective agents.

Materials and Methods: Polyampholytes were prepared by free radical copolymerization in water at 55°C, with 10% (w/v) total monomer loading and 1:1 ratio of APM and AA or methacrylamidopropyltrimethylammonium chloride (MAPTAc) and AA and 1 mol% initiator (Vazo-56, relative to total monomer), with polymerizations stopped at 60-80% conversion as determined by 1H-NMR. The copolymers were purified by dialysis and isolated by freeze drying. The pI was measured by turbidimetric titration and the LCST by UV-vis spectrophotometry using a heated sample holder. Protein aggregation inhibition was studied by heating 3 mg/ml lysozyme PBS solutions with or without 1 %wt polymer at 90oC for 10 min.

Results and Discussion: The pI of PAPM-co-AA is close to 8.3, with the polymer solution showing cloudiness in a broad pH range around the pI (between pH 7 to 9). The polymer solubility increases with NaCl concentration, and finally soluble with 200 mM NaCl. The reversible soluble to insoluble (LCST) transition during heating was measured by UV-vis at pI with 225 mM NaCl, and the LCST is at 60oC. However, the PMAPTAc-co-AA does have pH or temperature sensitivity. To measure the protein aggregation inhibition, lysozyme was mixed with both PAPM-co-AA and PMAPTAc-co-AA and heated at 90oC for 10 min. Before heating the neat lysozyme solution is clear; the one with PAPM-co-AA is cloudy because the pH is close to pI because the polymer forms a liquid coacervate phase; and the other one with PMAPTAc-co-AA is clear because the PMAPTAc-co-AA is not a pH or temperature sensitive polymer. After heating, the lysozyme solution precipitates, the one with PAPM-co-AA retains similar cloudiness but the other one with PMAPTAc-co-AA becomes cloudy. That indicates that PAPM-co-AA can inhibit lysozyme from aggregating upon heating, and this is attributed to partitioning of the protein into the protective liquid polymer coacervate phase.

Conclusion: The PAPM-co-AA is a protein-like polymer with pH and temperature induced soluble to insoluble transition in water. The solubility in water is pH, [NaCl] and temperature related. Preliminary results shows the polymer has potential ability to protect proteins during heating, and the key factor should be the thermally induced phase separation of PAPM-co-AA.

NSERC (the discovery and CREATE programs); The OCE-RE program of Ontario

Keywords: temperature, protein, polymer, Environmental response

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: Poster

Topic: Environmentally sensitive biomaterials

Citation: Zhao J, Pinto K, Burke NA and Stöver HD (2016). Temperature and ph sensitive polyampholytes used as protein aggregation inhibitors. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01301

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.